Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners listed on this page.

Company Trademark Status Update Alerts are email updates of the latest trademarks' status change on company level. Click here to get the alert for FREE!

Page 1 of 4

1234
Goods and Services: Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV...
LIVE (Circa: 2021)

REVERSIR

Goods and Services: Promoting public awareness about primary hyperoxaluria among affected individuals and their f...
LIVE (Circa: 2021)

TAKE ON PH1

Goods and Services: Maintaining a clinical registry database for patients with genetic mutations that cause enzym...
LIVE (Circa: 2021)

ELEVATE

Goods and Services: Maintaining a clinical registry database for patients with inherited disorders of the liver a...
LIVE (Circa: 2021)

BONAPH1DE

Goods and Services: Promoting public awareness about primary hyperoxaluria among affected individuals and their f...
LIVE (Circa: 2021)

BEHIND THE STONE

Goods and Services: Pharmaceutical preparations for the treatment of amyloidosis
LIVE (Circa: 2020)

AMVYTTRA

Goods and Services: Pharmaceutical preparations for the treatment of amyloidosis
LIVE (Circa: 2020)

AMVUTTRA

Goods and Services: Maintaining a clinical registry database for patients with genetic mutations; maintaining a r...
LIVE (Circa: 2020)

RNAI EVIDENCE

Goods and Services: Maintaining a clinical registry database for patients with mutations of the transthyretin gen...
LIVE (Circa: 2020)

CONTTRIBUTE

Goods and Services: Promoting public awareness about primary hyperoxaluria among affected individuals and their f...
LIVE (Circa: 2020)

TAKE ON PH1

Goods and Services: Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmace...
LIVE (Circa: 2020)

Mark Words (NOT AVAILABLE)

Goods and Services: Pharmaceutical preparations for the treatment of primary hyperoxaluria
LIVE (Circa: 2020)

Mark Words (NOT AVAILABLE)

Goods and Services: Pharmaceutical preparations for the treatment of porphyria
LIVE (Circa: 2020)

Mark Words (NOT AVAILABLE)

Goods and Services: Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmace...
LIVE (Circa: 2019)

FAMATTRY

Goods and Services: Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, inf...
LIVE (Circa: 2019)

KIRNAKO

Goods and Services: Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, inf...
LIVE (Circa: 2019)

OFREMKO

Goods and Services: Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, inf...
LIVE (Circa: 2019)

OTETREVI

Goods and Services: Pharmaceutical preparations for the treatment of central nervous system, ocular, hepatic, inf...
LIVE (Circa: 2019)

SISRELNA

Goods and Services: Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmace...
LIVE (Circa: 2019)

ONPATTRO

Goods and Services: Pharmaceutical preparations for the treatment of primary hyperoxaluria
LIVE (Circa: 2019)

OXLUMO

Hot News! On Friday, April 23, 2021, a U.S. federal trademark registration number 90667344 was filed for ELEVATE by Alnylam Pharmaceuticals, Inc. with the description Maintaining a clinical registry database for patients with genetic mutations that cause enzyme defects and acute hepatic porphyria; maintaining a registry on the clinical outcomes of acute hepatic porphyria in patients over time.

Hot News! On Friday, April 23, 2021, a U.S. federal trademark registration number 90667433 was filed for BONAPH1DE by Alnylam Pharmaceuticals, Inc. with the description Maintaining a clinical registry database for patients with inherited disorders of the liver and primary hyperoxaluria; maintaining a registry on the clinical outcomes of primary hyperoxaluria in patients over time.

Hot News! On Friday, April 23, 2021, a U.S. federal trademark registration number 90667583 was filed for BEHIND THE STONE by Alnylam Pharmaceuticals, Inc. with the description Promoting public awareness about primary hyperoxaluria among affected individuals and their families.

Hot News! On Friday, April 30, 2021, a U.S. federal trademark registration number 90683589 was filed for TAKE ON PH1 by Alnylam Pharmaceuticals, Inc. with the description Promoting public awareness about primary hyperoxaluria among affected individuals and their families.

Hot News! On Friday, May 7, 2021, a U.S. federal trademark registration number 90696853 was filed for REVERSIR by Alnylam Pharmaceuticals, Inc. with the description Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection.